Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items at this level: 139.

A

Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324

Ahmad, HA, Baker, JF, Østergaard, M et al. (3 more authors) (2019) Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial. Advances in Therapy, 36 (9). pp. 2384-2393. ISSN 0741-238X

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Alase, AA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Vital, EM orcid.org/0000-0003-1637-4755 et al. (3 more authors) (2015) IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism. The Journal of Investigative Dermatology, 135 (12). pp. 2935-2943. ISSN 0022-202X

Alcacer-Pitarch, B, Siddle, HJ, Buch, MH et al. (3 more authors) (2011) Foot health needs in people with systemic sclerosis: an audit of foot health care provision. Clinical Rheumatology, 30 (12). pp. 1611-1615. ISSN 0770-3198

Alfuraih, AM orcid.org/0000-0002-4655-7248, O'Connor, P, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2019) Muscle shear wave elastography in idiopathic inflammatory myopathies: a case–control study with MRI correlation. Skeletal Radiology, 48 (8). pp. 1209-1219. ISSN 0364-2348

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (3 more authors) (2019) Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography. International Journal of Rheumatic Diseases, 22 (10). pp. 1891-1899. ISSN 1756-1841

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (2 more authors) (2019) Muscle stiffness in rheumatoid arthritis is not altered or associated with muscle weakness: a shear wave elastography study. Modern Rheumatology. ISSN 1439-7595

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O’Connor,, P et al. (2 more authors) (2019) The effect of ageing on shear wave elastography muscle stiffness in adults. Aging Clinical and Experimental Research, 31 (12). pp. 1755-1763. ISSN 1594-0667

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71 (9). pp. 1400-1412. ISSN 2326-5191

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78 (9). pp. 1151-1159. ISSN 0003-4967

Aydin, SZ, Gunal, EK, Ozata, M et al. (4 more authors) (2017) Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission. Clinical and Experimental Rheumatology, 35 (5). pp. 853-856. ISSN 0392-856X

Aydin, SZ, Pay, S, Inanc, N et al. (4 more authors) (2017) Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience. Clinical and Experimental Rheumatology, 35 (3). pp. 508-511. ISSN 0392-856X

B

Backhouse, MR orcid.org/0000-0003-0056-8467, Hensor, EMA orcid.org/0000-0002-5245-4755, White, D et al. (3 more authors) (2013) Concurrent validation of activity monitors in patients with rheumatoid arthritis. Clinical Biomechanics, 28 (4). pp. 473-479. ISSN 0268-0033

Backhouse, MR orcid.org/0000-0003-0056-8467, Keenan, A-M orcid.org/0000-0003-0926-0397, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (8 more authors) (2011) Use of conservative and surgical foot care in an inception cohort of patients with rheumatoid arthritis. Rheumatology, 50 (9). pp. 1586-1595. ISSN 1462-0324

Baraliakos, X, Conaghan, PG orcid.org/0000-0002-3478-5665, D'Agostino, M-A et al. (5 more authors) (2019) Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities. European Journal of Rheumatology, 6 (1). pp. 37-45. ISSN 2147-9720

Bennett, AN, McGonagle, D, O'Connor, P et al. (5 more authors) (2008) Severity of baseline magnetic resonance imaging–evident sacroiliitis and HLA–B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis & Rheumatism, 58 (11). pp. 3413-3418. ISSN 0004-3591

Betteridge, Z, Tansley, S, Shaddick, G et al. (14 more authors) (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. Journal of Autoimmunity, 101. pp. 48-55. ISSN 1756-1841

Bissell, LA, Adu, D and Emery, P orcid.org/0000-0002-7429-8482 (2015) The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjögren syndrome , or overlap syndromes. In: Turner, NW, Lameire, N, Goldsmith, DJ, Winearls, CJ, Himmelfarb, J, Remuzzi, G, Bennet, WG, de Broe, ME, Chapman, JR, Covic, A, Jha, V, Sheerin, N and Unwin, R, (eds.) Oxford Textbook of Clinical Nephrology. Oxford University Press . ISBN 9780199592548

Braun, J, Baraliakos, X, Deodhar, A et al. (5 more authors) (2019) Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology (Oxford, England), 58 (5). pp. 859-868. ISSN 1462-0324

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Bryden, SR, Pingen, M orcid.org/0000-0001-5689-9076, Lefteri, DA et al. (16 more authors) (2020) Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site. Science Translational Medicine, 12 (527). eaax2421. ISSN 1946-6234

Buch, MH orcid.org/0000-0002-8962-5642, Boyle, DL, Rosengren, S et al. (10 more authors) (2009) Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Annals of the Rheumatic Diseases, 68 (7). pp. 1220-1227. ISSN 0003-4967

Buch, MH orcid.org/0000-0002-8962-5642, Vital, EM orcid.org/0000-0003-1637-4755 and Emery, P orcid.org/0000-0002-7429-8482 (2008) Abatacept in the treatment of rheumatoid arthritis. Arthritis Research and Therapy, 10 Suppl 1 (S5). S5-. ISSN 1478-6354

Burska, AN orcid.org/0000-0003-3321-9087, Thu, A, Parmar, R et al. (7 more authors) (2019) Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis. Rheumatology, 58 (11). pp. 2015-2024. ISSN 1462-0324

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2019) Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International. ISSN 0172-8172

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2018) On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International, 38 (12). pp. 2225-2231. ISSN 0172-8172

C

Cipolletta, E, Di Matteo, A orcid.org/0000-0003-0867-7051, Incorvaia, A et al. (3 more authors) (2019) When chest pain is not "just" Tietze's syndrome: a case of non-Hodgkin's lymphoma. Clinical and Experimental Rheumatology, 37 (4). p. 714. ISSN 0392-856X

Ciurtin, C, Majeed, Y, Naylor, J et al. (4 more authors) (2010) TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan. BMC Musculoskeletal Disorders, 11 (1). 111. ISSN 1471-2474

Coates, LC orcid.org/0000-0002-4756-663X, Lubrano, E, Perrotta, FM et al. (3 more authors) (2019) What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? Journal of Rheumatology, 46 (1). pp. 38-42. ISSN 0315-162X

Coates, LC, Mahmood, F, Freeston, J orcid.org/0000-0003-0358-338X et al. (3 more authors) (2019) Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Rheumatology. kez369. ISSN 1462-0324

Coates, LC orcid.org/0000-0002-4756-663X, Orbai, A-M, Morita, A et al. (6 more authors) (2018) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology, 2 (1). 24. ISSN 2520-1026

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) The RA-MAP Consortium: A working model for academia-industry collaboration. Nature Reviews Rheumatology, 14 (1). pp. 53-60. ISSN 1759-4790

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology, 14 (2). p. 119. ISSN 1759-4790

Crawshaw, DP, Helliwell, PS, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2010) Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial. BMJ, 340. c3037. ISSN 1468-5833

D

De Marco, G, Berekméri, A, Coates, LC et al. (10 more authors) (2019) Non Topical Pharmacological Treatment of Early, Untreated (DMARD-Naive, Systematic Therapy-Naive) Psoriatic Disease: a Systematic Review. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 904.

Duquenne, L, Gul, H and Emery, P (2019) Safety evaluation of Adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view. Expert opinion on drug safety, 8 (1). ISSN 1474-0338

E

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

El-Sherbiny, YM, Md Yusof, MY, Psarras, A et al. (11 more authors) (2019) B cell tetherin: a flow‐cytometric cell‐specific assay for response to Type‐I interferon predicts clinical features and flares in SLE. Arthritis & Rheumatology. ISSN 2326-5191

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Bykerk, VP et al. (4 more authors) (2019) Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD Open, 5 (1). e000840. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Furst, DE, Kirchner, P et al. (3 more authors) (2019) Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data. Rheumatology and Therapy. ISSN 2198-6584

Emery, P orcid.org/0000-0002-7429-8482, Horton, S, Dumitru, RB et al. (5 more authors) (2020) Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P, Mankia, K and Nam, JL (2017) Individuals at risk of rheumatoid arthritis – The evolving story. Best Practice & Research Clinical Rheumatology, 31 (1). pp. 1-2. ISSN 1521-6942

Emery, P, Pope, JE, Kruger, K et al. (4 more authors) (2018) Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review. Advances in Therapy, 35 (10). pp. 1535-1563. ISSN 0741-238X

Emery, P orcid.org/0000-0002-7429-8482, Rondon, J, Parrino, J et al. (8 more authors) (2019) Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology, 58 (5). pp. 849-858. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Van Keep, M, Beard, S et al. (6 more authors) (2018) Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. PharmacoEconomics, 36 (8). pp. 1015-1027. ISSN 1170-7690

Emery, P orcid.org/0000-0002-7429-8482, Vlahos, B, Szczypa, P et al. (9 more authors) (2019) Long-term drug survival of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. The Journal of Rheumatology. ISSN 0315-162X

F

Farrow, M, Grainger, AJ, Tan, AL orcid.org/0000-0002-9158-7243 et al. (6 more authors) (2019) Normal values and test–retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle. British Journal of Radiology, 92 (1101). 20190143. ISSN 0007-1285

Fent, G, Mankia, K, Erhayiem, B et al. (10 more authors) (2019) First cardiovascular MRI study in individuals at-risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody mediated role for accelerated atherosclerosis. Annals of the Rheumatic Diseases, 78 (8). pp. 1138-1140. ISSN 0003-4967

Fisher, BA, Emery, P orcid.org/0000-0002-7429-8482, Pitzalis, C et al. (2 more authors) (2019) Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome? Annals of the Rheumatic Diseases, 78 (4). e28-e28. ISSN 0003-4967

Freeston, JE orcid.org/0000-0003-0358-338X, Coates, LC orcid.org/0000-0002-4756-663X, Helliwell, PS et al. (4 more authors) (2010) Is There Sub-Clinical Joint Disease in Early Psoriatic Arthritis? A Clinical Comparison with Power Doppler Ultrasound. In: Rheumatology. Annual Meeting of the British Society of Rheumatology, 21-23 Apr 2010, Birmingham, UK. Oxford University Press .

G

Ganguly, P, J-El-Jawhari, J, Burska, AN et al. (3 more authors) (2019) The Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype. Stem Cells International. 5197983. ISSN 1687-966X

Garcia-Montoya, L, Gul, H and Emery, P (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research, 7.

Garcia-Montoya, L, Villota-Eraso, C, Yusof, Y et al. (2 more authors) (2020) Lessons For Rituximab Therapy In Patients With Rheumatoid Arthritis – 15 years of experience. The Lancet. ISSN 0140-6736 (In Press)

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

Goel, N, FitzGerald, O, Gladman, DD et al. (6 more authors) (2019) GRAPPA 2018 Project Report. The Journal of Rheumatology Supplement, 95. pp. 54-57. ISSN 0380-0903

Gossec, L, Kirkham, B, Rahman, P et al. (4 more authors) (2018) Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Gul, HL, Eugenio, G, Rabin, T et al. (5 more authors) (2019) Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes. Rheumatology. kez330. ISSN 1462-0324

H

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

Helliwell, P, Deodhar, A, Gottlieb, AB et al. (7 more authors) (2019) Comparing Composite Measures of Disease Activity in Psoriatic Arthritis: Results From a Randomized Phase 2 Trial with Guselkumab. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 1843.

Helliwell, PS, Coates, LC, Chew, NS et al. (7 more authors) (2019) Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial. Journal of Rheumatology. 181385. ISSN 0315-162X

Helliwell, PS, Favier, G, Gladman, DD et al. (6 more authors) (2019) Best-practice Indicators in Psoriatic Disease Care. The Journal of Rheumatology Supplement, 95. pp. 38-45. ISSN 0380-0903

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Buch, MH orcid.org/0000-0002-8962-5642 et al. (20 more authors) (2018) Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, United Kingdom. Oxford University Press .

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Ling, SF et al. (20 more authors) (2019) Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis. Rheumatology, 58 (8). pp. 1400-1409. ISSN 1462-0324

Hinks, A, Ke, X, Barton, A et al. (9 more authors) (2009) Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis & Rheumatism, 60 (1). pp. 251-257. ISSN 0004-3591

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Hurnakova, J, Filippucci, E, Cipolletta, E et al. (11 more authors) (2019) Prevalence and distribution of cartilage damage at the metacarpal head level in rheumatoid arthritis and osteoarthritis: an ultrasound study. Rheumatology, 58 (7). pp. 1206-1213. ISSN 1462-0324

I

Inomata, H, Bissell, L-A orcid.org/0000-0002-2789-4652, Naraghi, K et al. (6 more authors) (2016) FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime. In: Annals of the Rheumatic Diseases. EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 475.

J

Jadon, DR, Chandran, V, Ogdie, A et al. (12 more authors) (2019) Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology Supplement, 95. pp. 11-19. ISSN 0380-0903

Jani, M, Dixon, WG, Kersley-Fleet, L et al. (7 more authors) (2017) Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open, 3 (1). e000314. ISSN 2056-5933

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High Frequency of Anti-Drug Antibodies and Association of Random Drug Levels with Efficacy in Certolizumab Pegol Treated Patients with Rheumatoid Arthritis: Results from the BRAGGSS Cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

K

Kay, J, Dörner, T, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2019) Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar. Annals of the Rheumatic Diseases. ISSN 0003-4967

Kitas, GD, Nightingale, P, Armitage, J et al. (4 more authors) (2019) A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology, 71 (9). pp. 1437-1449. ISSN 2326-5191

M

Mackie, SL, Pease, CT, Fukuba, E et al. (5 more authors) (2015) Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Annals of the Rheumatic Diseases, 72 (12). pp. 2188-2192. ISSN 0003-4967

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Mahmoud, K, Zayat, AS, Yusof, Y et al. (4 more authors) (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatology, 58 (8). key422. pp. 1353-1360. ISSN 1462-0324

Mankia, K, Briggs, C and Emery, P orcid.org/0000-0002-7429-8482 (2020) How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis? Journal of Rheumatology, 47 (2). pp. 305-306. ISSN 0315-162X

Mankia, K, Cheng, Z, Do, T et al. (10 more authors) (2019) Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti–Cyclic Citrullinated Protein Antibody–Positive At-Risk Adults Without Arthritis. JAMA Network Open, 2 (6). e195394. ISSN 2574-3805

Mankia, K, D'Agostino, MA and Emery, P (2018) Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al. Annals of the Rheumatic Diseases. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Murillo-González, J et al. (2 more authors) (2019) Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: What's the real meaning?' by Deng et al. Annals of the Rheumatic Diseases. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Rowbotham, E et al. (12 more authors) (2019) MRI Inflammation of the Hand Interosseous Tendons occurs in anti-CCP positive at-risk individuals and may precede the development of clinical synovitis. Annals of the Rheumatic Diseases, 78 (6). pp. 781-786. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (4 more authors) (2019) Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Annals of the Rheumatic Diseases, 78 (1). pp. 43-50. ISSN 0003-4967

Mankia, K, Di Matteo, A orcid.org/0000-0003-0867-7051 and Emery, P orcid.org/0000-0002-7429-8482 (2019) Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. Journal of Autoimmunity. ISSN 0896-8411

Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2019) Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nature Reviews Rheumatology, 15 (11). pp. 687-695. ISSN 1759-4790

Marzo-Ortega, H, McGonagle, DG, Haugeberg, G et al. (3 more authors) (2003) Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Arthritis and Rheumatism, 62 (10). pp. 1020-1021. ISSN 0004-3591

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

McInnes, I, Mease, P, Hjuler, KF et al. (2 more authors) (2019) Brodalumab in psoriatic arthritis (PsA): 24-week results from the phase III AMVISON-1 and -2 trials. In: Journal of the American Academy of Dermatology. AAD 2019: American Academy of Dermatology Annual Meeting, 01-05 Mar 2019, Washington, DC, USA. Elsevier , AB28-AB28.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Edward, S et al. (6 more authors) (2019) Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus. Lupus, 28 (11). pp. 1320-1328. ISSN 0961-2033

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191

Mease, P, Coates, LC, Helliwell, PS et al. (14 more authors) (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet, 392 (10162). pp. 2367-2377. ISSN 0140-6736

Mease, PJ, Gladman, DD, Collier, DH et al. (5 more authors) (2019) Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial. Arthritis & Rheumatology, 71 (7). pp. 1112-1124. ISSN 2326-5191

Mease, PJ, Palmer, JB, Hur, P et al. (7 more authors) (2019) Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology, 33 (5). pp. 886-892. ISSN 0926-9959

Mease, PJ, Smolen, JS, Behrens, F et al. (11 more authors) (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the Rheumatic Diseases, 79 (1). pp. 123-131. ISSN 0003-4967

Michaud, K, Pope, JE, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2019) Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. Rheumatology and Therapy, 6 (3). pp. 409-419. ISSN 2198-6584

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

Morgan, AW orcid.org/0000-0003-1109-624X, Robinson, JI orcid.org/0000-0001-5425-7520, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (10 more authors) (2010) Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Research, 12 (2). R57. R57-R57. ISSN 1465-9913

Mortimer, I, Bissell, LA, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (12 more authors) (2019) Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology, 58 (9). kez114. pp. 1684-1686. ISSN 1462-0324

Mughal, S, Moghul, I, Yu, J et al. (28 more authors) (2017) Pheno4J: A gene to phenotype graph database. Bioinformatics, 33 (20). pp. 3317-3319. ISSN 1367-4803

N

Nam, JL, Villeneuve, E, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (13 more authors) (2014) Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the Rheumatic Diseases, 73 (1). pp. 75-85. ISSN 0003-4967

O

Orozco, G, Hinks, A, Eyre, S et al. (19 more authors) (2009) Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Human Molecular Genetics, 18 (14). pp. 2693-2699. ISSN 0964-6906

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

P

Pan, Y, Norton, S, Gwinnutt, JM et al. (7 more authors) (2019) Not all moderate disease is the same – Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. PLOS ONE, 14 (5). e0215999. ISSN 1932-6203

Peterfy, C, DiCarlo, J, Emery, P orcid.org/0000-0002-7429-8482 et al. (7 more authors) (2019) Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 46 (8). pp. 887-895. ISSN 0315-162X

Ponchel, F orcid.org/0000-0002-3969-7701, Burska, A orcid.org/0000-0003-3321-9087, Hunt, L et al. (6 more authors) (2020) T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management. Scientific Reports. ISSN 2045-2322 (In Press)

Q

Quinn, MA, Green, MJ, Marzo-Ortega, H et al. (5 more authors) (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis and Rheumatism, 48 (11). pp. 3039-3045. ISSN 0004-3591

R

Ridgley, LA, Anderson, AE, Maney, NJ et al. (7 more authors) (2019) IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function. Frontiers in Immunology, 10. 1535. ISSN 1664-3224

Romão, VC, Vital, EM orcid.org/0000-0003-1637-4755, Fonseca, JE et al. (1 more author) (2017) Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? Arthritis Research & Therapy, 19 (1). 239. ISSN 1478-6354

S

Sanjurjo-Rodriguez, C, Baboolal, TG, Burska, AN orcid.org/0000-0003-3321-9087 et al. (5 more authors) (2019) Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patients. Scientific Reports, 9. 9321. ISSN 2045-2322

Savage, L, Goodfield, M, Horton, L et al. (6 more authors) (2019) Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis: A Fifty‐Two–Week, Prospective, Open‐Label Feasibility Study. Arthritis and Rheumatology, 71 (4). pp. 626-631. ISSN 2326-5191

Savic, L, Savic, S orcid.org/0000-0001-7910-0554 and Hopkins, PM orcid.org/0000-0002-8127-1739 (2020) Anaphylaxis to sugammadex: should we be concerned by the Japanese experience? British Journal of Anaesthesia. ISSN 0007-0912

Savic, S orcid.org/0000-0001-7910-0554, Ouboussad, L, Dickie, LJ et al. (10 more authors) (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Journal of Autoimmunity, 50. pp. 59-66. ISSN 0896-8411

Smolen, JS, Choe, J-Y, Weinblatt, ME et al. (7 more authors) (2020) Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD Open, 6 (1). e001096. ISSN 2056-5933

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. The Lancet, 393 (10188). pp. 2303-2311. ISSN 0140-6736

T

Tan, AL orcid.org/0000-0002-9158-7243, Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D et al. (5 more authors) (2017) 21st century state of rheumatoid arthritis management in the uk. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 786.

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis. Arthritis and Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) Patients achieving sustained deep remission, deep remission or sustained remission of rheumatoid arthritis are more likely than other responders to maintain remission or low disease activity after dose reduction or withdrawal of etanercept. Arthritis Research and Therapy, 21. 164. ISSN 1478-6354

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 21 (1). 164. ISSN 1478-6354

Taylor, PC, Lee, YC, Fleischmann, R et al. (12 more authors) (2019) Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial. Journal of Clinical Medicine, 8 (6). 831. ISSN 2077-0383

Traylor, M, Knevel, R, Cui, J et al. (17 more authors) (2019) Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases. PLoS ONE, 14 (10). ARTN: e0223246. ISSN 1932-6203

V

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

van der Heijde, D, Schiff, M, Tanaka, Y et al. (6 more authors) (2019) Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. RMD Open, 5 (1). e000898. ISSN 2056-5933

W

Whitworth, J, Smith, PS, Martin, J-E et al. (41 more authors) (2018) Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. American Journal of Human Genetics, 103 (1). pp. 3-18. ISSN 0002-9297

Williams, AE, Cherry, L, Blake, A et al. (5 more authors) (2016) An Investigation into the Scale and Impact of Self-Reported Foot Problems Associated with Systemic Lupus Erythematosus: A Study Protocol and Survey Questionnaire Development. Musculoskeletal Care, 14 (2). pp. 110-115. ISSN 1478-2189

Y

Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2019) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324 (In Press)

Z

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

This list was generated on Fri Feb 21 03:53:49 2020 GMT.